The Regent™ aortic mechanical valve offers surgeon-friendly implantability, featuring a low valve implant height that helps ensure coronary ostia clearance. Two distinct cuff types—FlexCuff™ or Standard Cuff—provide you with different options. The Regent™ valve features exceptional hemodynamics in small aortic root patients.1*
Because prosthesis-patient mismatch (PPM) can be problematic in the aortic position, Abbott designed the Regent™ valve specifically to avoid this issue. The orifice-to-annulus ratio of the Regent™ valve ensures large effective orifice areas (EOAs) and reduces PPM.2
The Regent™ valve shows low thromboembolism, thrombosis, and bleeding over a wide international normalized ratio (INR) range, making this valve an excellent choice.3-6
*Measured one year post-surgery.
Learn about the features of the Regent™ Aortic Mechanical Heart Valve.
Catalog Number | Tissue Annulus Diameter (mm) | Geometric Orifice Area (cm²) | Implant Height Open (mm) | Overall Height Open (mm) | Cuff Outer Diameter (mm) |
---|---|---|---|---|---|
Standard Cuff | |||||
19 AGN‑751 | 19 | 2.4 | 6.1 | 11.6 | 24.7 |
21 AGN‑751 | 21 | 2.9 | 7.3 | 13.0 | 26.7 |
23 AGN‑751 | 23 | 3.5 | 8.0 | 14.3 | 28.7 |
25 AGN‑751 | 25 | 4.0 | 8.2 | 14.6 | 30.7 |
27 AGN‑751 | 27 | 4.7 | 9.1 | 15.4 | 32.7 |
FlexCuff™ | |||||
19 AGFN‑756 | 19 | 2.4 | 6.1 | 11.6 | 27.0 |
21 AGFN‑756 | 21 | 2.9 | 7.3 | 13.0 | 29.0 |
23 AGFN‑756 | 23 | 3.5 | 8.0 | 14.3 | 31.0 |
25 AGFN‑756 | 25 | 4.0 | 8.2 | 14.6 | 33.0 |
27 AGFN‑756 | 27 | 4.7 | 9.1 | 15.4 | 35.0 |
Indication for Use
The SJM Regent™ Mechanical Heart Valve is intended for use as a replacement valve in patients with a diseased, damaged, or malfunctioning aortic valve. This device may also be used to replace a previously implanted aortic prosthetic heart valve.
Contraindications
The SJM Regent™ Mechanical Heart Valve is contraindicated for individuals unable to tolerate anticoagulation therapy.
Warnings
Precautions
Potential Adverse Events
Complications associated with replacement mechanical heart valves include, but are not limited to:
hemolysis; infections; thrombus; or thromboembolism; valve dehiscence; unacceptable hemodynamic performance; hemorrhagic complications secondary to anticoagulation therapy; prosthetic failure; and heart failure or death.
Any of these complications may require reoperation or explantation of the device.
MAT-2011657 v1.0